跳至主要内容
临床试验/JPRN-UMIN000018069
JPRN-UMIN000018069招募中未知

The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity. - The clinical trial to examine the efficacy of the intravitreal injection of Bevacizumab for severe ROP.

Gunma University Hospital Department of Ophthalmology0 个研究点目标入组 4 人开始时间: 2017年6月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The patient who judged inappropriate as a subject by pediatrician. 2)In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

研究者

发起方
Gunma University Hospital Department of Ophthalmology

相似试验